// App-Quantinova.ai

POS0053 (2021) : RHEUMATOID ARTHRITIS AND THE RISK OF COVID-19 DIAGNOSIS, HOSPITALISATION AND DEATH: A POPULATION-BASED MULTI-STATE COHORT ANALYSIS INCLUDING 5,586,565 PEOPLE IN CATALONIA, SPAIN

Researchers

Presenter

  • A. Vivekanantham

Principal Investigators

  • E. Burn

  • T. Duarte-Salles

  • D. Prieto-Alhambra

Medical Centers

  • University of Oxford, Centre for Rehabilitation Research, Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences (NDORMS), Oxford, United Kingdom

  • Nuffield Orthopaedic Centre, Department of Pathology, Oxford, United Kingdom

  • Fundació Inst. Univ.ri per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain

  • Erasmus Medical Center, General Practice, Rotterdam, Netherlands

Locations

  • United Kingdom

  • Spain

  • Netherlands

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

  • Infectious Diseases (ID)

Disease

  • Rheumatoid arthritis

  • Coronavirus disease

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A